Honegr, J.; Dolezal, R.; Malinak, D.; Benkova, M.; Soukup, O.; Almeida, J.S.F.D.d.; Franca, T.C.C.; Kuca, K.; Prymula, R.
Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery. Molecules 2018, 23, 102.
https://doi.org/10.3390/molecules23010102
AMA Style
Honegr J, Dolezal R, Malinak D, Benkova M, Soukup O, Almeida JSFDd, Franca TCC, Kuca K, Prymula R.
Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery. Molecules. 2018; 23(1):102.
https://doi.org/10.3390/molecules23010102
Chicago/Turabian Style
Honegr, Jan, Rafael Dolezal, David Malinak, Marketa Benkova, Ondrej Soukup, Joyce S. F. D. de Almeida, Tanos C. C. Franca, Kamil Kuca, and Roman Prymula.
2018. "Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery" Molecules 23, no. 1: 102.
https://doi.org/10.3390/molecules23010102
APA Style
Honegr, J., Dolezal, R., Malinak, D., Benkova, M., Soukup, O., Almeida, J. S. F. D. d., Franca, T. C. C., Kuca, K., & Prymula, R.
(2018). Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery. Molecules, 23(1), 102.
https://doi.org/10.3390/molecules23010102